Current Status and Progress of Early Lung Cancer Screening under the
Normal State of COVID-19 Epidemic Prevention and Control.
10.3779/j.issn.1009-3419.2020.101.47
- Author:
Yuyang WANG
1
;
Na ZHOU
2
;
Dong LIU
2
;
Xiaochun ZHANG
2
Author Information
1. Department of Medicine, Qingdao University, Qingdao 266000, China.
2. The Affiliated Hospital of Qingdao University, Qingdao 266000, China.
- Publication Type:Journal Article
- Keywords:
Early screening;
Epidemic prevention and control;
Lung neoplasms
- MeSH:
COVID-19/epidemiology*;
China/epidemiology*;
Early Detection of Cancer;
Epidemics;
Humans;
Lung Neoplasms/prevention & control*
- From:Chinese Journal of Lung Cancer
2021;24(1):31-35
- CountryChina
- Language:Chinese
-
Abstract:
Lung cancer is the malignant tumor with the highest incidence in China. Early detection and identification of symptomatic lung cancer patients and timely screen out asymptomatic patients from high-risk groups require multiple cooperation. At present, although combined imaging, serology, genomics, proteomics and other methods have been combined to screen for suspected lung cancer, there are still problems such as missed diagnosis and misdiagnosis. Meanwhile, the spread of the corona virus disease 2019 (COVID-19) epidemic has brought new challenges to early lung cancer screening. Under the normalization of epidemic prevention and control, the work of early lung cancer screening should be changed accordingly: improve the population's awareness of cancer prevention and control, strengthen the management of medical procedures, improve the efficiency of tumor detection, optimize detection technology, and utilize internet and big data platforms rationally. We should establish an ideal model, combining multiple screening methods, which is streamlined and efficient for early lung cancer screening under normal epidemic prevention and control.
.
